P

Inventor

PETERS KEVIN GENE

US11 patents
⚠️ This page may combine multiple inventors who share the name “PETERS KEVIN GENE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

AERPIO THERAPEUTICS INC

5 patents
US9949956B2Apr 24, 2018

Compounds, compositions, and methods for preventing metastasis of cancer cells

AERPIO THERAPEUTICS INC21 citations94
US9174950B2Nov 3, 2015

Compounds, compositions, and methods for preventing metastasis of cancer cells

AERPIO THERAPEUTICS INC32 citations94
US9096555B2Aug 4, 2015

Methods for treating vascular leak syndrome

AERPIO THERAPEUTICS INC32 citations94
US8883832B2Nov 11, 2014

Compounds, compositions, and methods for preventing metastasis of cancer cells

AERPIO THERAPEUTICS INC38 citations94
US9926367B2Mar 27, 2018

Antibodies that bind human protein tyrosine phosphatase beta (HPTPbeta) and uses thereof

AERPIO THERAPEUTICS INC23 citations92

PROCTER & GAMBLE

2 patents
US7226755B1Jun 5, 2007

HPTPbeta as a target in treatment of angiogenesis mediated disorders

PROCTER & GAMBLE68 citations94
US7632862B2Dec 15, 2009

Pharmaceutical compositions that modulate HPTPbeta activity

PROCTER & GAMBLE35 citations89

Warner Chilcott Company

1 patent
US7973142B2Jul 5, 2011

Antibodies that bind human protein tyrosine phosphatase beta (HPTPβ)

Warner Chilcott Company46 citations95

ROTELLO ROCCO JAMIE

1 patent
US8524235B2Sep 3, 2013

Method for treating coronary artery disease using antibody binding human protein tyrosine phosphatase beta(HPTPbeta)

ROTELLO ROCCO JAMIE35 citations93

EYEPOINT PHARMACEUTICALS INC

1 patent
US11814425B2Nov 14, 2023

Antibodies that bind human protein tyrosine phosphatase beta (HPTPbeta) and uses thereof

EYEPOINT PHARMACEUTICALS INC2 citations71

AERPIO PHARMACEUTICALS INC

1 patent
US10952992B2Mar 23, 2021

Methods of treating intraocular pressure with activators of Tie-2

AERPIO PHARMACEUTICALS INC4 citations71